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ABSTRACT
Background Chromosome 15q24 microdeletion
syndrome is a rare genomic disorder characterised by
intellectual disability, growth retardation, unusual facial
morphology and other anomalies. To date, 20 patients
have been reported; 18 have had detailed breakpoint
analysis.
Aim To further delineate the features of the 15q24
microdeletion syndrome, the clinical and molecular
characterisation of ﬁfteen patients with deletions in the
15q24 region was performed, nearly doubling the
number of reported patients.
Methods Breakpoints were characterised using
a custom, high-density array comparative hybridisation
platform, and detailed phenotype information was
collected for each patient.
Results Nine distinct deletions with different
breakpoints ranging in size from 266 kb to 3.75 Mb were
identiﬁed. The majority of breakpoints lie within
segmental duplication (SD) blocks. Low sequence
identity and large intervals of unique sequence between
SD blocks likely contribute to the rarity of 15q24
deletions, which occur 8e10 times less frequently than
1q21 or 15q13 microdeletions in our series. Two small,
atypical deletions were identiﬁed within the region that
help delineate the critical region for the core phenotype
in the 15q24 microdeletion syndrome.
Conclusion The molecular characterisation of these
patients suggests that the core cognitive features of the
15q24 microdeletion syndrome, including developmental
delays and severe speech problems, are largely due to
deletion of genes in a 1.1eMb critical region. However,
genes just distal to the critical region also play an
important role in cognition and in the development of
characteristic facial features associated with 15q24
deletions. Clearly, deletions in the 15q24 region are
variable in size and extent. Knowledge of the breakpoints
and size of deletion combined with the natural history and
medical problems of our patients provide insights that will
inform management guidelines. Based on common
phenotypic features, all patients with 15q24 microdeletions
should receive a thorough neurodevelopmental evaluation,
physical, occupational and speech therapies, and regular
audiologic and ophthalmologic screening.
INTRODUCTION
The introduction of genome-wide approaches to
identify deletions and duplications throughout the
human genome has facilitated the discovery of
numerous novel causes for intellectual disability
(ID), autism, and other developmental disorders.
1 2
In the clinical work-up of undiagnosed intellectual
disability, array comparative genomic hybridisation
(aCGH) has the ability to make a diagnosis in
10e30% of cases. Recently, an international
consensus has been reached that chromosomal
microarray should be a ﬁrst-tier clinical diagnostic
test for individuals with developmental disabilities or
congenital anomalies.
3 It has also been shown that in
many patients abnormal chromosomal microarray
testing inﬂuences medical care by precipitating
specialty referral, diagnostic imaging, or speciﬁc
laboratory testing.
4 For patients with well known
classical microdeletion syndromes such as 22q11.2
deletion syndrome, Prader-Willi syndrome and
Williams syndrome, extensive data exist on clinical
features observed in patients, and management
guidelines have been developed. For newly discovered
microdeletion/duplication syndromes, case reports
and family support groups such as Unique, the Rare
Chromosome Disorder Support Group (http://www.
rarechromo.org), offer limited resources. Systematic
characterisation of newly reported patients provides
much needed information for clinicians and patients.
Recurrent microdeletion of chromosome 15q24
was described as a new genomic disorder after
identiﬁcation of patients with overlapping deletions,
intellectual disability and similar clinical features.
5
The 15q24 region is a complex genomic region with
at least ﬁve segmental duplication (SD) blocks, also
known as low copy repeats. These SD blocks,
referred to as breakpoints A, B, C, D, and E, have
varying amounts and degrees of sequence similarity
to one another and can facilitate non-allelic
homologous recombination (NAHR) at meiosis,
leading to deletion of the intervening sequence.
NAHR between different SD blocks can lead to
deletions of various sizes and with different break-
points. To date, 18 patients with 15q24 deletions
and detailed breakpoint analysis have been described
in the medical literature.
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Copy-number variationsphenotype has been delineated with major features that include
growth retardation, microcephaly, dysmorphic facial features,
genital anomalies, and digital anomalies. Here we report clinical
and molecular data for 15 patients with deletions in the 15q24
region, nearly doubling the number of reported patients. Among
these, there are nine distinct deletions with different breakpoints,
and two patients carry small, atypical deletions within the region
that help delineate the critical region for core phenotypes in the
15q24 microdeletion syndrome. Finally, we offer recommenda-
tions for evaluation and management of patients with 15q24
deletion syndrome.
SUBJECTS AND METHODS
Study subjects
Fifteen individuals (10 males and ﬁve females) with a 15q24
deletion were included in this study. Fourteen cases were
initially ascertained based on clinical aCGH or single nucleotide
polymorphism microarray analysis. The deletion in patient 13
was initially identiﬁed using a custom bacterial artiﬁcial chro-
mosome (BAC) array as previously described.
5 Clinical infor-
mation and facial photographs were obtained from the referring
clinicians or families. Several of the patients met through the
‘Unique’ support group and shared information between them-
selves and their clinicians. This study was approved by institu-
tional review boards at the University of Washington, Rhode
Island Hospital, and Spokane.
Molecular studies
Reﬁnement of the 15q24 deletion intervals in 13/15 cases for
which DNA was available was conducted using a custom high
density oligonucleotide array with 7450 probes in the 15q24
region (hg18, chr15: 69000000e77000000) with an average
probe spacing of 1074 bp. When possible, parent-of-origin
studies were performed using microsatellite markers within the
deleted region.
RESULTS
Identiﬁcation of novel 15q24 deletions
We report 15 patients with deletions in the 15q24 region
(table 1, ﬁgure 1). Deletions range from 266 kb to 3.75 Mb in
size. The majority of deletions have both breakpoints in one of
the SD blocks in this region of chromosome 15. We have adopted
the nomenclature put forth by El-Hattab and colleagues
8 for the
SD blocks in the region and will refer to them as breakpoints
AeE( ﬁgure 1, table 1). Four patients have nearly identical
2.6 Mb deletions with breakpoints in A and C, and four patients
have 3.1 Mb deletions with breakpoints in A and D. In addition,
we identiﬁed deletions with breakpoints in B and D (n¼1), B
and E (n¼1), and C and D (n¼1). Four patients have atypical
deletions with only one or no breakpoints within segmental
duplications (ﬁgure 1, table 1).
Atypical deletions
We identiﬁed four atypical deletions that have not yet been
reported in the literature. Patient 1 has a large de novo deletion
with both breakpoints in unique sequence. The proximal
breakpoint in this patient is in unique sequence proximal to
breakpoint A, and the distal breakpoint lies between B and C.
The deletion carried by patient 11 has a proximal breakpoint in
B and distal breakpoint that is distal to D. The smallest deletion
we detected was a de novo 266 kb deletion in patient 13
that involves only ﬁve genes (COMMD4, NEIL1, MAN2C1,
SIN3A, and PTPN9) within the region between breakpoints
C and D. Sequencing the breakpoints of this small deletion
revealed that it likely occurred by Alu-Alu recombination
(ﬁgure 2). Finally, we identiﬁed one severely affected patient
(patient 15) with a clinical diagnosis of Johanson-Blizzard
syndrome who has a 470 kb atypical distal 15q24 deletion that is
within the region between D and E but has breakpoints in
unique sequence. The signiﬁcance of this deletion is unclear, and
parents were unavailable to determine inheritance. In addition,
patient 14 has a small, de novo deletion with breakpoints at C
and D (chr15: 73.38e73.88 Mb); although both breakpoints are
in SD blocks, this deletion has not been previously reported to
our knowledge.
Clinical details of the study subjects
We were able to obtain clinical information for all 15 patients
(table 2, ﬁgure 3). In order to assess for possible genotypee
phenotype correlations, we grouped patients according to dele-
tion size and location. We will ﬁrst discuss features in patients
whose deletion includes the proposed critical region between
breakpoints BeC (patients 2e12). We will then consider
patients whose deletion includes only the region between
breakpoints CeD (patient 13 and 14). Finally, we consider
clinical features in patient 1, whose deletion involves only the
proximal 300 kb of the BeC region. Because the inher-
itancedand therefore clinical signiﬁcancedof the deletion in
patient 15 is not known, we will not discuss this patient further.
Deletions involving region BeC
Eleven patients had deletions including the 1.1 Mb proposed
critical region between breakpoints BeC. The subjects were
diagnosed from immediately after birth to young adulthood.
Most were born full term after uncomplicated pregnancies. In
the newborn period, several had feeding difﬁculties or failure to
thrive. One patient was born with Pierre Robin sequence and
required prolonged neonatal intensive care unit stay.
In terms of development, the majority of patients had motor
delays. For eight patients who reported the age at which inde-
pendent walking was achieved, this milestone was achieved
between 18 and 33 months (average 26 months). Ten of 11
patients had signiﬁcant expressive speech delay with three
described as non-verbal. Intellectual disability ranged from mild
to severe. Dysmorphic facial features included high anterior
hairline, prominent forehead, and epicanthal folds. Four patients
had deep-set eyes. Digital anomalies included short ﬁfth ﬁngers
with fourth ﬁnger camptodactyly in one patient and thenar
hypoplasia in another. Three patients were described as having
long ﬁngers.
Neurologically, several patients had hypotonia. Seven of 11
patients in this group had had a brain MRI; six had normal
results. One patient had subtle abnormalities in the frontal lobe.
Table 1 Frequency of 15q24 deletions with different breakpoints
Breakpoints
Deletion
size
N (this
study) N (literature)
681 0 e14
Total
N
Size, identity
of ﬂanking
SDs*
AeC 2.6 Mb 4 1 5 25 kb, >98%
AeD 3.1 Mb 4 6 10 21 kb, 94%
BeD 1.7 Mb 1 1 2 e
BeE 3.8 Mb 1 5 6 42 kb, >95%
CeD 500 kb 1 0 1 27 kb, >93%
Atypical Varies 4 4 8
Total 15 17 32
*Based on NCBI Build 36/hg18, the size and percentage identity of the longest stretch of
directly oriented, highly homologous sequence is listed.
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Copy-number variationsFigure 1 High density array comparative genomic hybridisation (aCGH) data for the 15q24 region (NCBI Build 36, chr15:69500000e76500000
shown) for 13 new patients. Breakpoints are labelled as breakpoints A through E as described in the text. For each individual, deviations of probe log2
ratios from zero are depicted by vertical grey/black lines, with those exceeding a threshold of 1.5 standard deviations from the mean probe ratio
coloured green and red to represent relative gains (duplications) and losses (deletions), respectively. Genes are depicted in blue below the aCGH data.
The red bars represent the deletions for two patients (9 and 10) for which additional DNA was unavailable as well as previously published cases. The
breakpoints are as described in clinical reports (patients 9 or 10) or within the publications noted.
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Copy-number variationsTwo patients had reported at least one seizure. Three patients
were diagnosed with autism.
Of note, seven patients in this group had eye or vision
abnormalities including strabismus (n¼3), blindness (n¼1),
anisocoria (n¼2), and coloboma (n¼1). Four patients suffered
from hearing loss, and six reported recurrent ear infections, ear
effusions or ear tubes.
Cardiac evaluations were performed in seven patients. One
patient had pulmonic stenosis, and another had a patent
foramen ovale, patent ductus arteriosus, and peripheral
pulmonic stenosis. Though genital abnormalities have been
commonly reported in patients with 15q24 deletions, only 1/8
males with deletions involving region BeC had hypospadias.
One female patient had an imperforate anus. A few of the
patients had endocrine problems. One patient had delayed
puberty and insulin dependent diabetes, and another patient had
acanthosis nigricans. Two patients had obesity later in life.
Deletions involving only region CeD
Two patients were found to have small, previously unreported
deletions between breakpoints C and D. As described above
(Atypical deletions), patient 13 has a de novo 266 kb deletion
that involves only ﬁve genes. Patient 14 has a de novo 500 kb
deletion with breakpoints in the ﬂanking SDs. Both of these
patients have borderline to mild intellectual disability with IQ
scores of 65 and 73, respectively. In addition, although patient 13
did not speak until age 4, both patients now have reasonable
speech and communication skills. Interestingly, both patients
have dysmorphic features similar to patients with deletions of
the BeC region including large forehead, and both have short
ﬁfth ﬁngers.
Patient 1: proximal deletion
Patient 1 has a 2.37 Mb deletion that begins proximal to BP-A
and extends only 300 kb into the 1.1 Mb critical region. She
presented with mild motor delays, an IQ of 47 at 15 years of age,
dysmorphic features (ﬁgure 3), periventricular nodular hetero-
topia, and brachydactyly type E. The brachydactyly was not
present in other family members, suggesting that one of more
genes in the large, proximal deletion may be responsible.
Inheritance
In 11 cases, parents were available for analysis, and in each case
the deletion was de novo. In four cases, we were unable to
determine inheritance. In addition, we determined that the
deletion originated on the maternal chromosome in three cases.
We were unable to determine parent of origin for the remaining
cases.
DISCUSSION
The 15q24 microdeletion syndrome is a newly characterised
microdeletion syndrome. We performed an extensive clinical and
molecular characterisation of 15 patients. In the majority of cases
the microdeletion was initially identiﬁed by clinical aCGH
performed because of multiple congenital anomalies and/or intel-
lectual disability. Of these, eight patients were identiﬁed at
Signature Genomic Laboratories between November 2007 and
December 2009. During this period, 21820 patients were evaluated.
Figure 2 Breakpoint sequence for patient 13, who has the smallest deletion detected in our series. (A) Array comparative genomic hybridisation data
for the deletion in patient 13, as displayed in ﬁgure 1. Segmental duplications are shown at the top. Note that the breakpoints lie outside of the
segmental duplication regions. (B) Sequence data across the breakpoint revealed that each breakpoint was located within an Alu sequence: an AluSx
at the proximal breakpoint and an AluJo at the distal breakpoint. Comparison of the two sequences revealed a 14 bp stretch of perfect sequence
identity at the breakpoints.
J Med Genet 2012;49:110e118. doi:10.1136/jmedgenet-2011-100499 113
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Copy-number variationsThis suggests that, despite a genomic architecture that predicts
recurrent rearrangement, deletions in the region account for only
3e4/10 000 cases that are sent for clinical aCGH studies. In
comparison, the rate at which recurrent deletions of 15q13 or 1q21
were identiﬁe dd u r i n gt h es a m et i m ep e r i o dw a se i g h t f o l dt o1 0 -
fold higher. The larger interval of unique sequence between SD
blocks (2.6e3 . 8M bc o m p a r e dt o1 . 3 e1.5 Mb for 1q21 and 15q13)
and the lower sequence identity between SD blocks in direct
orientation likely contribute to the lower frequency of 15q24
deletion events.
The 15q24 region contains several clusters of segmental
duplications that are thought to facilitate non-allelic homolo-
gous recombination resulting in recurrent deletion.
8 16 The
deletions in our series of patients, which ranged from 266 kb to
3.75 Mb, support this assertion. Eleven of the 15 deletions had
both breakpoints in segmental duplications ﬂanking the deleted
region. Three patients had deletions with both breakpoints in
unique sequence. One deletion had one breakpoint in unique
sequence and the other in a segmental duplication. The most
common deletions in our series, found in four patients each,
were the 2.6 Mb deletion between breakpoints A and C and the
3.1 Mb deletion between breakpoints A and D (table 1, ﬁgure 1).
Evaluation of previously reported deletions suggest that the
deletion between breakpoints A and D occurs most frequently
and accounts for about one third of deletions in the region (10/
32 reported; table 1). Deletions between A and C and between B
and E occur with approximately equal frequency, accounting for
15e20% of deletions. The breakpoint combinations are consis-
tent with an NAHR mechanism between directly oriented
segmental duplications. Breakpoints A and C share a w25 kb
directly oriented sequence block with >98% sequence identity.
Similarly, breakpoints A and D share a w21 kb directly oriented
sequence block with 94% identity. Breakpoints B and E share
a 42 kb stretch of >95% identity, and C and D share a 27 kb
stretch of >93% identity. Conversely, there are no large stretches
of highly homologous and directly oriented repeats between
blocks A and B, A and E, B and C, or B and D, suggesting the
deletions are much less likely to occur via NAHR between these
blocks.
Our analysis of the clinical features in our series of
patients with 15q24 deletions is largely consistent with previous
reports.
6 891 11 21 4Common features, present in more than 50%
of the patients and that should prompt consideration of this
diagnosis, include dysmorphic facial features, including
Figure 3 Clinical features of patients with 15q24 deletions. Photographs and hand radiographs of patient 1 (A) showing pronounced shortening of the
fourth metacarpals; photographs of patient 4 (B), patient 6 at 9 months and 2 years (C), patient 7 at 13 months and 6 years (D), patient 9 (E), patient
10 (F), patient 12 (G), and patient 14 (H).
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Copy-number variationsa prominent forehead, high anterior hairline, prominent nasal
bridge, and micrognathia. Other features include deep-set eyes,
strabismus, or other ocular anomalies. Short metacarpals and
proximally placed thumbs may also be a clue to diagnosis. A
history of failure to thrive and developmental delay is typical.
Severe speech delay or absence of speech is a consistent feature
in patients with typical deletions. Diaphragmatic hernia has
been reported in some patients with the deletion,
11 12 but no
patients in our series reported this. Similarly, we found only 1/8
males with hypospadias.
It is important to note that we identiﬁed nine distinct dele-
tions with different breakpoints in 15 patients. In fact, the
deletions in patients 1e5 have no overlap with the deletions in
patients 13, 14, and 15. Combining the deletions in our series
with those in the literature, 28% of reported deletions are
‘private’ mutations seen in a single patient. The vast majority of
reported deletions include the region between breakpoints B and
C and most also include the CeD region. We identiﬁed two
patients with small, atypical deletions that lie within the region
between breakpoints C and D. Notably, both of these patients
had only mild or borderline ID, with IQ scores of 65 and 73.
Unlike the majority of patients with larger deletions, both have
developed reasonable speech. This suggests that the severity of
the core cognitive deﬁcits of the 15q24 microdeletion syndrome
are due to deletion of one or more genes with the 1.1 Mb critical
region between breakpoints B and C containing 24 RefSeq genes.
However, given the delays and dysmorphic features in our two
atypical cases, some or all of the eight genes between C and D,
and indeed the ﬁve genes deleted in case 13, must be important
for normal development and behaviour. Furthermore, review of
photographs for patients with deletions that do not include the
region between C and D (patients 13 and 14 from this study,
patient 3 in Andrieux et al
6 and McInnes et al
13) suggest that
their facial features are slightly less striking. This would suggest
that some of the genes in the CeD region are important for the
syndromic facies described for 15q24 deletions. On the other
hand, we found that patients with deletions including the BP
BeC region were more likely to have eye abnormalities. In
addition, cardiac features and seizures were noted in several
patients with deletions including the BeC region, but not in
patients 1, 13 or 14, whose deletions do not include the critical
region.
Based on common features of our patients, we feel that
certain management recommendations can be made. Since there
is a high incidence of eye and ear anomalies, ophthalmological
evaluation and audiology evaluation should be routine referrals.
Additional screening for genitourinary and cardiac anomalies
should be considered. A formal developmental evaluation and
careful screening for autism and related entities could help
diagnose these potential problems early and initiate targeted
services. Families should be counselled to observe closely for
seizures, since there appears to be an increased risk in these
patients. The families of our patients have reported that support
group information is especially helpful to them.
In conclusion, the molecular and clinical characterisation of 15
individuals with the 15q24 microdeletion syndrome further
deﬁnes the phenotypic features associated with this novel
syndrome and provides further insight into the critical region for
core features of this syndrome.
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